Cannabis News

AgraFlora received a cannabis research licence, giving it the ability to develop cannabis-infused beverages at its facility in Toronto.

AgraFlora Organics International (CSE:AGRA,OTCPK:AGFAF) has been awarded a cannabis research licence from Health Canada, giving the company the ability to develop cannabis-infused beverage formulations at its GMP bottling facility in Toronto, Ontario.

As quoted in the press release:

In anticipation of the Research Licence, AgraFlora began comprehensive retrofit initiatives at the Toronto Bottling Facility including the completion of a cannabis research laboratory (the “Research Laboratory”) within its current GMP-certified premises. The Research Laboratory consists of state-of-the-art equipment for weighing, handling and processing microdosages of CBD and THC compounds, including magnetic mixers, homogenizers and high-pressure liquid chromatograph (“HPLC”).

The Company plans to immediately commence cannabinoid-related research and development activities, including:

  • Establishment of extraction protocols to isolate specific desirable compounds, including CBD, THC and THCV;
  • Cannabinoid extract infusion analysis relating to formulation and pilot batching;
  • Identification of process and physiochemical product attributes paired with analytically guided optimization;
  • Development of optimized blend formulations for water solubility and shelf stability ratios/forms;
  • High-pressure homogenization to produce superfine emulsions from cannabis oil; and,
  • Centrifugal partition chromatography to develop compounds in a powdered format.

Click here to read the full press release.

MARKETS

Markets
TSX19078.64-144.10
TSXV626.34-18.57
DOW31029.31+82.32
S&P 5003818.830.00
NASD11177.89-3.65
ASX6700.20-63.40

COMMODITIES

Commodities
Gold1809.61-9.21
Silver20.41-0.33
Copper3.69-0.09
Palladium1955.50-6.50
Platinum901.00-18.00
Oil108.83-0.95
Heating Oil3.960.00
Natural Gas6.37-0.13

DOWNLOAD FREE REPORTS

×